// App-Quantinova.ai

: BENEFITS OF RNA SEQUENCING IN DETECTING RECURRENT AND NOVEL FUSION TRANSCRIPTS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Rabia Shahswar

Principal Investigators

  • Claudia Haferlach

  • Wencke Walter

  • Sven O. Twardziok

  • Stephan Hutter

  • Manja Meggendorfer

  • Wolfgang Kern

  • Torsten Haferlach

  • Anna Stengel

Medical Centers

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • Munich Leukemia Laboratory, Munich, Germany.

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved